At the gene levels, genes with recurrent amplifications in breast cancer showed different degrees of concordance: 100% for ERBB2 and FGFR1, 96% for CCND1, but 88% for MYC, suggesting possible differences for driver genes. The gene discussed is MYC; the disease is breast cancer.